The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial
Population-based genomic screening is at the forefront of a new approach to disease prevention. Yet the lack of diversity in genome wide association studies and ongoing debates about the appropriate use of racial and ethnic categories in genomics raise key questions about the translation of genomic...
Enregistré dans:
Auteurs principaux: | Jennifer Elyse James, Leslie Riddle, Barbara Ann Koenig, Galen Joseph |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/64a70eed548c4deaad4dba9ea765bc09 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
par: Jennifer Elyse James, et autres
Publié: (2021) -
Precision oncology- the future of personalized cancer medicine?
par: Ann M. Bode, et autres
Publié: (2017) -
Personalized immunotherapy in cancer precision medicine
par: Kazuma Kiyotani, et autres
Publié: (2021) -
SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
par: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Publié: (2021) -
Precision medicine: the foundation of future cancer therapeutics
par: Seung Ho Shin, et autres
Publié: (2017)